Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
2 "Jin Joo Park"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Erratum
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes
Jin Joo Park
Diabetes Metab J. 2021;45(5):796-796.   Published online September 30, 2021
DOI: https://doi.org/10.4093/dmj.2021.0239
Corrects: Diabetes Metab J 2021;45(2):146
  • 3,247 View
  • 99 Download
  • 4 Crossref
PDFPubReader   ePub   

Citations

Citations to this article as recorded by  
  • Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts
    Ashot Avagimyan, Federica Fogacci, Nana Pogosova, Lev Kakrurskiy, Eugenia Kogan, Olga Urazova, Zhanna Kobalava, Liudmila Mikhaleva, Rositsa Vandysheva, Gioeva Zarina, Artem Trofimenko, Grizelda Navasardyan, Lusine Mkrtchyan, Mattia Galli, Zinaida Jndoyan,
    Current Problems in Cardiology.2024; 49(1): 102052.     CrossRef
  • Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China
    Yun Huang, Hua Zhou, Chongbo Fang, Lili Ma, Yuyu Zhang, Weibo Rong, Xiaoli Liu, Honghua Ye
    Journal of Cardiovascular Pharmacology.2024; 83(1): 86.     CrossRef
  • Evaluation of newly-developed glycated hemoglobin clinical analytic reagents and chromatography column on Tosoh HLC-723 G8 Analyzer
    Bo Yuan, Wei Yang, Na Zhang, Hongyan Shi, Shuangpeng Dong
    Practical Laboratory Medicine.2023; 37: e00338.     CrossRef
  • Defining the Phenotypes for Heart Failure With Preserved Ejection Fraction
    Dane Rucker, Jacob Joseph
    Current Heart Failure Reports.2022; 19(6): 445.     CrossRef
Review
Cardiovascular Risk/Epidemiology
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes
Jin Joo Park
Diabetes Metab J. 2021;45(2):146-157.   Published online March 25, 2021
DOI: https://doi.org/10.4093/dmj.2020.0282
Correction in: Diabetes Metab J 2021;45(5):796
  • 13,764 View
  • 1,206 Download
  • 51 Web of Science
  • 54 Crossref
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
The cardiovascular disease continuum begins with risk factors such as diabetes mellitus (DM), progresses to vasculopathy and myocardial dysfunction, and finally ends with cardiovascular death. Diabetes is associated with a 2- to 4-fold increased risk for heart failure (HF). Moreover, HF patients with DM have a worse prognosis than those without DM. Diabetes can cause myocardial ischemia via micro- and macrovasculopathy and can directly exert deleterious effects on the myocardium. Hyperglycemia, hyperinsulinemia, and insulin resistance can cause alterations in vascular homeostasis. Then, reduced nitric oxide and increased reactive oxygen species levels favor inflammation leading to atherothrombotic progression and myocardial dysfunction. The classification, diagnosis, and treatment of HF for a patient with and without DM remain the same. Until now, drugs targeting neurohumoral and metabolic pathways improved mortality and morbidity in HF with reduced ejection fraction (HFrEF). Therefore, all HFrEF patients should receive guideline-directed medical therapy. By contrast, drugs modulating neurohumoral activity did not improve survival in HF with preserved ejection fraction (HFpEF) patients. Trials investigating whether sodium-glucose cotransporter-2 inhibitors are effective in HFpEF are on-going. This review will summarize the epidemiology, pathophysiology, and treatment of HF in diabetes.

Citations

Citations to this article as recorded by  
  • Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis
    Yundong Peng, JiePing Wang, Xinyao Liu, Yanqing Zhou, Shaohui Jia, Jinrong Xu, Cheng Zheng
    Annals of Vascular Surgery.2024; 98: 365.     CrossRef
  • Diabetic Cardiomyopathy: 2023 Update by the International Multidisciplinary Board of Experts
    Ashot Avagimyan, Federica Fogacci, Nana Pogosova, Lev Kakrurskiy, Eugenia Kogan, Olga Urazova, Zhanna Kobalava, Liudmila Mikhaleva, Rositsa Vandysheva, Gioeva Zarina, Artem Trofimenko, Grizelda Navasardyan, Lusine Mkrtchyan, Mattia Galli, Zinaida Jndoyan,
    Current Problems in Cardiology.2024; 49(1): 102052.     CrossRef
  • Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes
    Rachel E. Aaron, Tiffany Tian, G. Alexander Fleming, David B. Sacks, James L. Januzzi, Rodica Pop-Busui, Ibrahim A. Hashim, Alan H. B. Wu, Ambarish Pandey, David C. Klonoff
    Journal of Diabetes Science and Technology.2024;[Epub]     CrossRef
  • Research Progress on the Relationship between HbA1c and Diabetes Complicated with Chronic Heart Failure
    ·依沙 迪达尔
    Advances in Clinical Medicine.2024; 14(01): 1117.     CrossRef
  • Association Between Use of Sodium-Glucose Cotransporter-2 Inhibitors or Angiotensin Receptor-Neprilysin Inhibitor and the Risk of Atherosclerotic Cardiovascular Disease With Coexisting Diabetes and Heart Failure
    Ya-Wen Lin, Chun-Hsiang Lin, Cheng-Li Lin, Che-Huei Lin, Ming-Hung Lin
    Journal of Cardiovascular Pharmacology and Therapeutics.2024;[Epub]     CrossRef
  • The Role of Epicardial Adipose Tissue in Acute Coronary Syndromes, Post-Infarct Remodeling and Cardiac Regeneration
    Kamil Krauz, Marcel Kempiński, Paweł Jańczak, Karol Momot, Maciej Zarębiński, Izabela Poprawa, Małgorzata Wojciechowska
    International Journal of Molecular Sciences.2024; 25(7): 3583.     CrossRef
  • Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy
    Yue Zeng, Yilang Li, Wenyue Jiang, Ning Hou
    Frontiers in Cardiovascular Medicine.2024;[Epub]     CrossRef
  • Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,496 adults using serial echocardiography
    Gyuri Kim, Tae Yang Yu, Jae Hwan Jee, Ji Cheol Bae, Mira Kang, Jae Hyeon Kim
    Diabetes & Metabolism.2024; : 101534.     CrossRef
  • SGLT2 Inhibitors in the Cardiovascular Disease
    Jin Joo Park
    The Journal of Korean Diabetes.2024; 25(1): 26.     CrossRef
  • Metabolic Alteration Bridging the Prediabetic State and Colorectal Cancer
    Antonino Colloca, Isabella Donisi, Camilla Anastasio, Maria Luisa Balestrieri, Nunzia D’Onofrio
    Cells.2024; 13(8): 663.     CrossRef
  • Inflammation in diabetes complications: molecular mechanisms and therapeutic interventions
    Lu Zhao, Haoran Hu, Lin Zhang, Zheting Liu, Yunchao Huang, Qian Liu, Liang Jin, Meifei Zhu, Ling Zhang
    MedComm.2024;[Epub]     CrossRef
  • Methods to predict heart failure in diabetes patients
    Alexander E. Berezin, Tetiana A Berezina, Uta C. Hoppe, Michael Lichtenauer, Alexander A. Berezin
    Expert Review of Endocrinology & Metabolism.2024; : 1.     CrossRef
  • Association between Dapagliflozin, Cardiac Biomarkers and Cardiac Remodeling in Patients with Diabetes Mellitus and Heart Failure
    Andrew Xanthopoulos, Nikolaos Katsiadas, Spyridon Skoularigkis, Dimitrios E. Magouliotis, Niki Skopeliti, Sotirios Patsilinakos, Alexandros Briasoulis, Filippos Triposkiadis, John Skoularigis
    Life.2023; 13(8): 1778.     CrossRef
  • Empagliflozin for Patients with Heart Failure and Type 2 Diabetes Mellitus: Clinical Evidence in Comparison with Other Sodium-Glucose Co-transporter-2 Inhibitors and Potential Mechanism
    Bo Liang, Rui Li, Peng Zhang, Ning Gu
    Journal of Cardiovascular Translational Research.2023; 16(2): 327.     CrossRef
  • Causes and Determinants of Heart Failure Readmissions Post Transcutaneous Aortic Valve Replacement: A Systematic Review and Meta-Analysis
    Farah Yasmin, Muhammad Aamir, Abdul Moeed, Kinza Iqbal, Aymen Iqbal, Muhammad Sohaib Asghar, Waqas Ullah, Indranee Rajapreyar, Yevgeniy Brailovsky
    Current Problems in Cardiology.2023; 48(1): 101428.     CrossRef
  • Discussion of a study on the role of EMS in prognosis of elderly patients with AHF
    Qingzhuo Yang, Hui Wu, Di Liu, Yunzhao Li, Gang Zhou, Dong Zhang, Yanfang Liu, Yi Li
    International Journal of Cardiology.2023; 377: 91.     CrossRef
  • The management correlation between metabolic index, cardiovascular health, and diabetes combined with cardiovascular disease
    Yi Zhang, Chao Liu, Yijing Xu, Yanlei Wang, Fang Dai, Honglin Hu, Tian Jiang, Yunxia Lu, Qiu Zhang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Evaluation and Management of Patients With Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    International Journal of Heart Failure.2023; 5(1): 1.     CrossRef
  • Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement
    Kyu-Sun Lee, Junghyun Noh, Seong-Mi Park, Kyung Mook Choi, Seok-Min Kang, Kyu-Chang Won, Hyun-Jai Cho, Min Kyong Moon
    Diabetes & Metabolism Journal.2023; 47(1): 10.     CrossRef
  • Lower Circulating Cell-Free Mitochondrial DNA Is Associated with Heart Failure in Type 2 Diabetes Mellitus Patients
    Tetiana A. Berezina, Mykola P. Kopytsya, Olga V. Petyunina, Alexander A. Berezin, Zeljko Obradovic, Lukas Schmidbauer, Michael Lichtenauer, Alexander E. Berezin
    Cardiogenetics.2023; 13(1): 15.     CrossRef
  • Novel model predicts diastolic cardiac dysfunction in type 2 diabetes
    Mingyu Hao, Xiaohong Huang, Xueting Liu, Xiaokang Fang, Haiyan Li, Lingbo Lv, Liming Zhou, Tiecheng Guo, Dewen Yan
    Annals of Medicine.2023; 55(1): 766.     CrossRef
  • Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide‐induced ERK/Egr‐1 pathway
    Qing Wu, Ming Zhao, Dongling Li, Xi He, Weijin Zang
    The FASEB Journal.2023;[Epub]     CrossRef
  • Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy
    Yangting Zhao, Binjing Pan, Xiaoyu Lv, Chongyang Chen, Kai Li, Yawen Wang, Jingfang Liu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Cardiorenal syndrome and diabetes: an evil pairing
    Ana Belén Méndez Fernández, Ander Vergara Arana, Aleix Olivella San Emeterio, Maria Antonieta Azancot Rivero, Toni Soriano Colome, Maria Jose Soler Romeo
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Therapeutic Potential of Hibiscus sabdariffa Linn. in Attenuating Cardiovascular Risk Factors
    Syaifuzah Sapian, Asma Ali Ibrahim Mze, Fatin Farhana Jubaidi, Nor Anizah Mohd Nor, Izatus Shima Taib, Zariyantey Abd Hamid, Satirah Zainalabidin, Nur Najmi Mohamad Anuar, Haliza Katas, Jalifah Latip, Juriyati Jalil, Nur Faizah Abu Bakar, Siti Balkis Budi
    Pharmaceuticals.2023; 16(6): 807.     CrossRef
  • Exploring the prospect of intrinsic wave propagation in evaluating myocardial stiffness among patients with type 2 diabetes
    Qiao Cheng, Xiao Huang, Xinying Fan, Jie Sun, Jun Zhang, Qiaoying Tang, Youbin Deng, Xiaojun Bi
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • The multidimensional prognostic index (MPI) predicts long-term mortality in old type 2 diabetes mellitus patients: a 13-year follow-up study
    F. Salis, E. Cossu, A. Mandas
    Journal of Endocrinological Investigation.2023; 47(1): 191.     CrossRef
  • PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy
    Tongtong Hu, Qingqing Wu, Qi Yao, Jiabin Yu, Kebing Jiang, Ying Wan, Qizhu Tang
    Metabolism.2023; 146: 155658.     CrossRef
  • Empagliflozin Reduces Interleukin-6 Levels in Patients with Heart Failure
    Michael Gotzmann, Pauline Henk, Ulrik Stervbo, Arturo Blázquez-Navarro, Andreas Mügge, Nina Babel, Timm H. Westhoff
    Journal of Clinical Medicine.2023; 12(13): 4458.     CrossRef
  • Features of the course and complications of acute myocardial infarction in type 2 diabetes mellitus
    M. N. Zatsepina, F. O. Ushanova, T. L. Bogacheva
    FOCUS. Endocrinology.2023; 4(2): 42.     CrossRef
  • Admission triglyceride-glucose index is predictor of long-term mortality and appropriate implantable cardiac defibrillator therapy in patients with heart failure
    Kazım S Özcan, Mert İ Hayıroğlu, Tufan Çınar
    Biomarkers in Medicine.2023; 17(10): 487.     CrossRef
  • Emerging Roles of Phospholipase C Beta Isozymes as Potential Biomarkers in Cardiac Disorders
    Antonietta Fazio, Camilla Evangelisti, Alessandra Cappellini, Sara Mongiorgi, Foteini-Dionysia Koufi, Irene Neri, Maria Vittoria Marvi, Michele Russo, Alessandra Ghigo, Lucia Manzoli, Roberta Fiume, Stefano Ratti
    International Journal of Molecular Sciences.2023; 24(17): 13096.     CrossRef
  • Research progress of dihydromyricetin in the treatment of diabetes mellitus
    Ziyuan Wang, Zhuoran Cao, Zhiying Yue, Zhengfeng Yang
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Assessment of subclinical left ventricular myocardial systolic dysfunction in type 2 diabetes mellitus patients with or without hypertension by global and segmental myocardial work
    Guang-An Li, Jun Huang, Xiao Sheng, Li Fan
    Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
  • Managing heart failure in diabetics with dual acting sotagliflozin—A review
    Kushal Seni, Pooja A Chawla
    Health Sciences Review.2023; 9: 100130.     CrossRef
  • Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study
    Shuping Yang, Xiangxiang Shi, Wanlu Liu, Zhaokai Wang, Ruoshui Li, Xianzhi Xu, Chaofan Wang, Lei Li, Ruili Wang, Tongda Xu
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Influence of Sociodemographic Variables and Healthy Habits on the Values of Insulin Resistance Indicators in 386,924 Spanish Workers
    Miguel Mestre Font, Carla Busquets-Cortés, José Ignacio Ramírez-Manent, Pilar Tomás-Gil, Hernán Paublini, Ángel Arturo López-González
    Nutrients.2023; 15(24): 5122.     CrossRef
  • The effect of dapagliflozin on ventricular arrhythmias, cardiac arrest, or sudden death in people with heart failure: a tick in another box for sodium-glucose cotransporter 2 inhibitors
    Theocharis Koufakis, George Giannakoulas, Pantelis Zebekakis, Kalliopi Kotsa
    Expert Opinion on Pharmacotherapy.2022; 23(3): 321.     CrossRef
  • The peculiar role of vitamin D in the pathophysiology of cardiovascular and neurodegenerative diseases
    Milijana Janjusevic, Giulia Gagno, Alessandra Lucia Fluca, Laura Padoan, Antonio Paolo Beltrami, Gianfranco Sinagra, Rita Moretti, Aneta Aleksova
    Life Sciences.2022; 289: 120193.     CrossRef
  • Mechanisms of cardiac dysfunction in diabetic cardiomyopathy: molecular abnormalities and phenotypical variants
    Francesca Romana Prandi, Isabella Evangelista, Domenico Sergi, Alberto Palazzuoli, Francesco Romeo
    Heart Failure Reviews.2022; 28(3): 597.     CrossRef
  • Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus
    Yu. G. Gorb, S. A. Serik, O. V. Tkachenko, V. V. Ryabukha
    Ukraïnsʹkij žurnal medicini, bìologìï ta sportu.2022; 7(1): 14.     CrossRef
  • Metabonomic Characteristics of Myocardial Diastolic Dysfunction in Type 2 Diabetic Cardiomyopathy Patients
    Mingyu Hao, Jianxin Deng, Xiaohong Huang, Haiyan Li, Huiting Ou, Xiangsheng Cai, Jiajie She, Xueting Liu, Ling Chen, Shujuan Chen, Wenlan Liu, Dewen Yan
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Serum Levels of Irisin Predict Cumulative Clinical Outcomes in Heart Failure Patients With Type 2 Diabetes Mellitus
    Alexander A. Berezin, Michael Lichtenauer, Elke Boxhammer, Ivan M. Fushtey, Alexander E. Berezin
    Frontiers in Physiology.2022;[Epub]     CrossRef
  • Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association
    Rodica Pop-Busui, James L. Januzzi, Dennis Bruemmer, Sonia Butalia, Jennifer B. Green, William B. Horton, Colette Knight, Moshe Levi, Neda Rasouli, Caroline R. Richardson
    Diabetes Care.2022; 45(7): 1670.     CrossRef
  • Von Willebrand factor (vWF) in patients with heart failure with preserved ejection fraction (HFpEF): A retrospective observational study
    Mayila Abudoukelimu, Bayinsilema Ba, Yan Kai Guo, Jie Xu
    Medicine.2022; 101(31): e29854.     CrossRef
  • Why Does the Intravenous Iron Supplementation Not Work in Heart Failure Patients on Hemodialysis?
    Jin Joo Park
    CardioMetabolic Syndrome Journal.2022; 2(2): 176.     CrossRef
  • Severe hypoglycemia and risk of hospitalization for heart failure in adults with diabetes treated with oral medications with or without insulin: A population-based study
    You-Bin Lee, Yoon-Jong Bae, Hoseob Kim, Jiyun Park, So Yoon Kwon, So Hee Park, Gyuri Kim, Kyu Yeon Hur, Jae Hyeon Kim, Sang-Man Jin
    Diabetes Research and Clinical Practice.2022; 192: 110083.     CrossRef
  • Blood Pressure Target in Type 2 Diabetes Mellitus
    Hyun-Jin Kim, Kwang-il Kim
    Diabetes & Metabolism Journal.2022; 46(5): 667.     CrossRef
  • Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
    Ruxin Wang, Juan Wu, Haowen Ye, Xiaofang Zhang, Lihong Wang
    Medicina.2022; 58(10): 1473.     CrossRef
  • HFpEF and Atrial Fibrillation: The Enigmatic Interplay of Dysmetabolism, Biomarkers, and Vascular Endothelial Dysfunction
    Jure Bosanac, Lara Straus, Marko Novaković, Daniel Košuta, Mojca Božič Mijovski, Jerneja Tasič, Borut Jug, Azizah Ugusman
    Disease Markers.2022; 2022: 1.     CrossRef
  • The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy
    Weiyi Xia, Xia Li, Qingping Wu, Aimin Xu, Liangqing Zhang, Zhengyuan Xia
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Microvascular Burden and Incident Heart Failure Among Middle-Aged and Older Adults With Type 1 or Type 2 Diabetes
    Fu-Rong Li, Daniel Nyarko Hukportie, Jing Yang, Huan-Huan Yang, Guo-Chong Chen, Xian-Bo Wu
    Diabetes Care.2022; 45(12): 2999.     CrossRef
  • C-reactive protein and statins in heart failure with reduced and preserved ejection fraction
    Jin Joo Park, Minjae Yoon, Hyoung-Won Cho, Hyun-Jai Cho, Kye Hun Kim, Dong Heon Yang, Byung-Su Yoo, Seok-Min Kang, Sang Hong Baek, Eun-Seok Jeon, Jae-Joong Kim, Myeong-Chan Cho, Shung Chull Chae, Byung-Hee Oh, Dong-Ju Choi
    Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
  • Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond
    Angela Sciacqua, Elena Succurro, Giuseppe Armentaro, Sofia Miceli, Daniele Pastori, Giuseppe Rengo, Giorgio Sesti
    Heart Failure Reviews.2021; 28(3): 667.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal